MEDOCHEMIE SINGAPORE PTE. LTD.

Medochemie Ltd was established in 1976 by Dr. Andreas Pittas and has since evolved into the largest pharmaceutical company in Cyprus and one of the top 200 generic drug manufacturers globally. Our growth reflects the broader rise of generics in global healthcare by moving from a limited role to a key provider of high-quality, affordable medicines worldwide. Today, we operate fifteen state-of-the-art manufacturing facilities: nine in Cyprus, one in the Netherlands, and five in Vietnam. Our production capabilities allow us to export to 122 countries, supported by 19 core offices and an extended network of trusted agents and partners. Our portfolio includes 630 pharmaceutical products under 5,145 marketing authorisations, spanning over 10 therapeutic categories, including prescription and over-the-counter medicines. Our team of 2,000 skilled professionals, 45% of whom are scientists, drives our commitment to excellence, innovation, and strict adherence to international quality standards. Medochemie is proud to contribute significantly to Cyprus' economy, accounting for 28.9% of the country’s industrial exports. We are also a founding member of Medicines for Europe (formerly EGA).